Background and Purpose-Paroxysmal atrial fibrillation (PAF) is often difficult to detect in patients with acute ischemic stroke. We aimed to assess the predictive value of a prolonged QT interval corrected for heart rate (QTc) in PAF detection after acute ischemic stroke. Methods-We enrolled 972 patients with acute ischemic stroke consecutively extracted from our observational stroke registry system. Exclusion criteria were as follows: (1) AF on the initial 12-lead ECG (n=171); (2) previously diagnosed PAF (n=47); and (3) the use of a cardiac pacemaker (n=10). Of the 972 patients, 744 (mean age, 67.6 years; men, 62.6%) were eligible for analysis. The clinical characteristics and 12-lead ECG findings of the patients with and without PAF were compared, and multiple logistic regression analysis was performed to identify predictors of poststroke PAF. Results-The poststroke cardiac work-up yielded 69 (9.3%) de novo PAF cases among the 744 patients. The QTc interval was significantly longer in patients with PAF than in those without PAF (436 versus 417 ms; P<0.001). Each 10-ms increase in the QTc interval was associated with an increased risk of PAF after multivariate adjustments (odds ratio, 1.41; 95% confidence interval, 1.24-1.61; P<0.001). The optimal threshold value of QTc interval calculated by a receiveroperating characteristic curve was 438 ms, and the area under the curve was 0.73 in this data set. Conclusions-The QTc interval prolongation is potentially a strong and useful predictor for poststroke PAF.
1
A trial fibrillation (AF) is a strong risk factor for ischemic stroke and a leading cause of cardioembolic stroke. 1 In particular, patients with AF with previous stroke are at high risk of recurrence. 2 Because anticoagulant therapy can remarkably reduce the risk of recurrence, 3 early identification of AF is crucial for targeted secondary prevention.
Persistent AF is usually easy to diagnose using the standard 12-lead ECG. However, paroxysmal AF (PAF) is often difficult to detect in patients with acute ischemic stroke (AIS) because such patients are frequently asymptomatic or present with sinus rhythm on ECGs, 4 because of which the prevalence of PAF is possibly underestimated and anticoagulants are underused. Repetitive and extended cardiac monitoring, including standard 12-lead ECG, 24-hour Holter ECG, and inpatient telemetry monitoring, are recommended to detect occult PAF in patients with AIS. 5 However, the optimal timing, duration, and method to detect PAF remain to be clarified, and the detection rate of PAF after stroke is limited. Therefore, it would be helpful to determine a factor predicting covert PAF in patients with sinus rhythms on ECGs.
The QT interval corrected for heart rate (QTc)-which represents the ventricular action potential duration-has long been established as a predictor of cardiac morbidity and mortality. 6, 7 Several large population-based studies have recently shown that a prolonged QTc interval is associated with an increased risk of AF development. [8] [9] [10] Moreover, small studies have suggested that patients with congenital long-QT syndrome (LQTS) have a greater risk of developing AF than the general population. 11, 12 Thus, we hypothesized that the QTc interval is potentially a good predictor of occult PAF in patients with AIS. In the present study, we aimed to assess the predictive value of a prolonged QTc interval for the detection of poststroke PAF, using data from our observational stroke registry system.
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incomplete clinical investigations or missing data, 972 patients were enrolled. Furthermore, we have excluded patients with the following characteristics: (1) AF on the initial 12-lead ECG (n=171); (2) previous PAF diagnosis before stroke (n=47); and (3) the use of cardiac pacemakers (n=10). Of the 972 patients, 744 were eligible for analysis. All patients were of East Asian ethnicity. All patients with stroke were diagnosed by a board-certified stroke neurologist on the basis of the findings from neurological observations, and MRI or computed tomography. Stroke severity was assessed according to the National Institute of Health Stroke Scale.
Cardiac Evaluations
Baseline resting standard 12-lead ECG was performed at the time of hospital admission. Twelve-lead ECG was recorded using a standard digital recorder (CardiofaxV; Nihon Kohden Co, Tokyo, Japan) at a gain of 10 mm/mV and a speed of 25 mm/s. ECG interpretation was conducted using Electro Cardiograph Analysis Program System 12 (Nihon Kohden Co). Electro Cardiograph Analysis Program System generates an additionally averaged ECG wave form from the beats obtained during a 10-s recording time. The QT interval is then automatically determined in the processed wave form and corrected for heart rate using the following formula: QTc=QT+(1000-RR)/7, on the basis of linear regression techniques. Electro Cardiograph Analysis Program System correction has been confirmed comparable with other formulae and shows similar tendency to Framingham correction (in-house data by Nihon Kohden Co). The linear regression formulae, including Electro Cardiograph Analysis Program System and Framingham, were reported to correct QT more reliably when compared with the nonlinear formulae, such as Bazetts. 13, 14 Considering the diurnal variation of QTc interval, 15 in analyzing QTc, we further divided the subjects into 2 groups according to time of admission: daytime (6:00 AM-6:00 PM; n=518) and nighttime (6:00 PM-6:00 AM; n=226).
All patients routinely underwent continuous bedside ECG monitoring for 48 hours immediately after admission, with the monitoring period extended depending on the case. We also routinely performed 24-hour Holter ECG. Therefore, ≥72 hours of ECG monitoring was conducted on every patient. PAF was defined as a self-terminating sequence of >30 s RR intervals and the presence of fibrillatory P waves. The presence of PAF (or atrial flutter) was determined on the basis of cardiac monitoring by inpatient telemetry and 24-hour Holter ECG. Moreover, each patient underwent transthoracic echocardiography without presuming the cause of stroke. All measurements and calculations were performed in accordance with the recommendations of the Japanese Circulation Society. Independent board-certified cardiologists reported all the 24-hour Holter ECG and transthoracic echocardiography results.
Baseline Risk Factors
Hypertensive patients were defined as those who were receiving antihypertensive treatment at the time of the event or those with consistently high systolic blood pressure (≥140 mm Hg) or diastolic blood pressure (≥90 mm Hg) for >1 week after admission. Patients with diabetes mellitus were defined as those who had previously been diagnosed with type 1 or 2 diabetes mellitus, or those with fasting blood glucose levels ≥126 mg/dL or blood glucose levels ≥200 mg/dL based on 2 random measurements. Patients with dyslipidemia were defined as those who had been receiving lipid-lowering treatment at the time of the stroke event, or those with a serum low-density lipoprotein cholesterol level ≥140 mg/dL or high-density lipoprotein cholesterol level ≤40 mg/dL or serum triglyceride level ≥150 mg/dL. The estimated glomerular filtration rate was calculated using the Modification of Diet in Renal Disease equation for Japan; chronic kidney disease was defined as an estimated glomerular filtration rate <60 mL/min per 1.73 m 2 . An intracranial artery stenosis of ≥50% was considered significant, as determined by MR angiography, 3-dimensional computed tomographic angiography, or digital subtraction angiography. The narrowest diameter of each stenosed vessel was measured and divided by the diameter of the normal vessel just distal to the lesion. If no suitable vessel existed beyond the lesion for measurement, the vessel proximal to it was used. Qualified neurologists checked the carotid artery ultrasounds; percent stenosis was calculated according to the European Carotid Surgery Trial (ECST) criteria, 16 and a stenosis of ≥50% was defined as significant. The criteria of absence of vascular cause in this study were based on the absence of both intracranial and carotid artery stenosis.
Statistical Analysis
We compared the clinical parameters of the patients with and without poststroke PAF. Intergroup differences were assessed by using the χ 2 test for categorical variables, and Student t test or Mann-Whitney U-test for continuous variables. To identify predictors of PAF, we performed multiple logistic regression analysis based on a forward stepwise method adjusted for age, sex, and all clinical variables with P<0.1 in the univariate analysis. Given the multicolinearities, supraventricular/ventricular arrhythmia and left ventricular hypertrophy were excluded from the model. Odds ratios and 95% confidence intervals were calculated. The optimal cutoff value of the QTc interval was calculated on the basis of the receiver-operating characteristic curve. In all analyzes, a value of P<0.05 was considered statistically significant.
Results
Of the 744 patients with AIS (mean age, 67.6 years; men, 62.6%), 69 (9.3%) were newly diagnosed with PAF based on the poststroke cardiac work-up. The median latency from hospital admission to PAF detection was 3 days, and in >90% of these patients, PAF was detected within 14 days after admission. Baseline characteristics of the study subjects are shown in Table 1 . Patients with and without poststroke PAF showed significant differences in age (73.4 versus 67.0 years; P<0.001), absence of vascular cause (78.3% versus 54.4%; P<0.001), congestive heart failure (11.6% versus 5.5%; P=0.043), left atrial dilation on transthoracic echocardiography (37.7% versus 16.6%; P<0.001), and admission National Institute of Health Stroke Scale score (10 versus 6; P<0.001). With regard to the initial 12-lead ECG findings, the QTc interval in patients with PAF was significantly longer than in those without PAF (436 versus 417 ms; P<0.001). Even when classified by time of admission, QTc interval was still prolonged in patients with PAF when compared with those without PAF by a significant difference (cases of daytime admission: 439 versus 417 ms; P<0.001; nighttime admission, 432 versus 418 ms; P<0.001). In addition, patients with PAF presented more frequently with AV conduction block (17.4% versus 9.0%; P=0.040) and premature atrial contraction (13.0% versus 3.7%; P=0.003) than those without PAF.
The Figure shows the prevalence of patients with poststroke PAF stratified by QTc interval. The prevalence of PAF was significantly higher in patients with QTc >450 and >440 ms than in those with ≤450 and ≤440 ms, respectively (34.5% versus 7.1%; P<0.001 and 27.5% versus 5.8%, P<0.001, respectively). A trend of slight increase in the prevalence of PAF was found in the short QTc interval subgroup; however, the difference was not statistically significant.
According to the multiple logistic regression analysis, the prolonged QTc interval was an independent predictor for PAF (QTc per 10-ms increase; odds ratio, 1.41; 95% confidence interval, 1.24-1.61; P<0.001; Table 2 ). The optimal threshold value of the QTc interval calculated by a receiver-operating characteristic curve was 438 ms (sensitivity, 59.4%; specificity, 83.7%), and the area under the curve was 0.73. 
Discussion
The present study showed that patients with AIS and a prolonged QTc interval on the initial 12-lead ECG had an increased risk of poststroke PAF. This relationship persisted after multivariable adjustment for possible confounding factors. According to the receiver-operating characteristic analysis, QTc interval seems to be an acceptable screening test at an early time point for detecting PAF in patients with AIS. QTc prolongation was still associated with PAF based on analysis, including the patients with premorbid PAF ( Figure I in the online-only Data Supplement). Our findings suggest that QTc prolongation might be a rapid, inexpensive, and useful marker for improving the detection rate of poststroke PAF.
Previous population-based studies have shown that individuals with a prolonged QTc interval have a high risk of developing PAF. [8] [9] [10] Mandyam et al 9 reported a hazard ratio of 1.11 per 10-ms increase of QTc interval for incident PAF. An increased risk of developing PAF has also been demonstrated in patients with congenital LQTS. 11, 12 These findings seem consistent with our results. In addition, Nielsen et al 8 showed the possibility of a higher risk of PAF in patients with shorter QTc interval, a similar tendency was also seen among our cohort.
The association of QTc interval prolongation with PAF may suggest that the duration of the ventricular action potential represents an easily identifiable marker of PAF, which may provide insights into the pathophysiology of this arrhythmia. 
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To our knowledge, there is a lack of strong evidence of the direct correlation between the atrial and ventricular action potential durations. However, Ordög et al 17 have investigated the mRNA expressions of several representative panels of cardiac ion channels in healthy human hearts and found that some important channels involved in cardiac repolarization are commonly abundant between the atrial and the ventricular tissues. Given that the expression level of the ion channel subunit-encoding mRNA is closely related to the electrophysiological behavior in the cardiac tissues, the duration of the atrial and ventricular repolarizations is potentially related. As discussed by Nielsen et al 8 and Mandyam et al, 9 the association between the QTc prolongation and AF may be explained by a mechanism of atrial torsades de pointes, which has been first recognized in the congenital LQTS-characterized by a susceptibility to ventricular tachyarrhythmias known as torsades de pointes. 18 Apparently, disordered repolarization is not confined to the ventricular myocardium because it also affects the atrial myocardium. In patients with LQTS, the duration of monophasic atrial action potentials was found to be prolonged; furthermore, after depolarizations in the atrium, similar to ventricular torsade de pointes, preceded the polymorphic atrial tachyarrhythmias. 18 Moreover, the murine LQTS model study showed that prolongation of the duration of the atrial action potential secondary to increased Na + current, caused by an impaired inactivation of the gate function, is sufficient to provoke early after depolarizations, which promote AF. 19 Interestingly, the QTc interval prolongation is associated with an increased risk of stroke, 20, 21 as well as the poststroke short-and long-term prognosis. 22, 23 However, the mechanism for these associations remains unclear. We speculated that this may be because of a higher prevalence of occult PAF in patients with a prolonged QTc interval and the higher likelihood of a severe or fatal cardioembolic stroke in patients with AF than in those without AF. 24
Limitations
It is important to acknowledge several limitations in our study mainly related to the retrospective design, generalizability, and low statistical power. Although the baseline ECGs were retrospectively collected, they were analyzed digitally using clinically validated software, to avoid any intraobserver or interobserver variability. With regard to the measurement of carotid artery stenosis by ultrasound, ECST criteria were adopted in our stroke registry system. Because ECST methodology tends to overestimate the degree of stenosis, 25 the number of patients with true absence of vascular cause might be higher than shown in Table 1 .
It should be noted that QTc interval can be modulated by several factors, such as the circadian rhythm, meals, smoking, physical activities, serum electrolytes, and medication. 15, 26, 27 Even at the same time of the day, the parasympathetic and sympathetic nervous system modulate QTc interval to different degrees. 28 To complicate matters further, AIS itself, particularly in the right insula 29, 30 or posterior circulation regions, 31 may prolong QTc interval. Although intraindividual QTc variability should have compensated to avoid possible bias, it was difficult to determine the relative influence of all above-mentioned factors. Furthermore, there is also considerable ethnic variability in QTc interval. 32, 33 However, bias because of ethnic variability is perceived to be small in the current study because we included only East Asian subjects.
The procedure for the poststroke cardiac work-up might also have some limitations. In the present study, all patients underwent 24-hour Holter ECG monitoring and continuous bedside monitoring for ≥48 hours. The duration of the bedside monitoring was further extended depending on the case, particularly in cases of cryptogenic stroke; it was not consistent among studied patients. This is potentially a vital bias because of the retrospective settings and might also lessen the comparability with relevant past reports. In a future prospective study, we plan to set a more standardized protocol of cardiac tests.
As mentioned above, we conducted ≥72 hours of ECG monitoring on every patient. According to a previous review, 24-hour Holter ECG monitoring, which is the most widely used screening test, led to the identification of PAF in only ≈5% of patients with AIS. 34 Seventy-two-hour ECG monitoring improved the PAF detection when compared with standard 24-hour Holter ECG; the number of patients in whom PAF was detected nearly doubled. 35 More recent evidence revealed that weeks 36 and years 37 of extended ECG monitoring yield much better results. Although a standard protocol for ECG monitoring with longer period would have been useful to avoid a possible bias of results, a complete cardiac evaluation for all patients with AIS in the same way would not be costeffective. In clinical practice, we should first identify patients with a high possibility of latent PAF and then conduct intensive investigations on them. We have previously reported that a slow sinus heart rate on 24-hour ECG monitoring possibly helps predict PAF in patients with stroke. 38 It has also been reported that several other ECG parameters, including premature atrial beats, 39 P wave duration, 40 P wave morphology, 41 incomplete right bundle brunch block, 42 and left ventricular hypertrophy 43 are associated with silent PAF. These ECG factors might be comprehensively considered in a future study.
Conclusions
We showed the possibility of using QTc interval on initial 12-lead ECG for poststroke PAF prediction. The present study may provide an important and useful information for the management of cryptogenic stroke and guide future prospective studies with larger multicenter cohorts aimed at validating our findings.
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Mortality
In addition to ischemic stroke and ICH, 5019 patients died during the study period (18.3%/y). The overall high mortality indicated a high-risk population. Among these, patients on no therapy and on aspirin had the highest mortality rate: 17.0%/y and 37.1%/y, respectively. Although patients on warfarin had a lower overall mortality, there was a progressive decrease in mortality with decreasing TTR (first quartile, 11.4%/y; second quartile, 8.9%/y; third quartile, 5.4%/y; and fourth quartile, 4.6%/y). The annual mortality of patients on dabigatran was 1.8%/y ( Figure VI in the online-only Data Supplement).
Discussion
To our knowledge, this is the first study to investigate the impact of TTR on the risk of stroke and ICH in Chinese patients with nonvalvular AF in a real-world clinical setting. In the present analysis, we first show that TTRs (median, 38.8%) were generally poor among Chinese AF patients. Second, the incidence of ischemic stroke decreased progressively with increasing TTR quartiles, ranging from 7.34%/y (first quartile) to 3.10%/y (fourth quartile), even on multivariate analysis. Indeed, patients on aspirin had a comparable incidence of ischemic stroke as those on warfarin in the lowest quartile of TTR (7.95%/y versus 7.34%/y), whereas the incidence of ischemic stroke in those on dabigatran was the lowest across all groups (2.24%/y). Third, the incidence of ICH decreased with increasing TTR quartiles among patients on warfarin, ranging from 1.37%/y (first quartile) to 0.74%/y (fourth quartile). Fourth, patients on dabigatran had the lowest incidence of ICH (0.32%/y), which was lower than that of patients on warfarin at the fourth quartile of TTR (ie, good quality anticoagulation control) or patients not receiving any antithrombotic therapy.
Despite a lower prevalence of AF in Chinese population (0.7%) in comparison with whites (1%-2%), the Chinese have a much higher overall disease burden because of its proportionally larger aged population. [19] [20] [21] Stroke prevention in AF in Chinese population remains challenging because of the lack of epidemiological data. Until recently, there has been a prevailing belief that Chinese patients with AF are at a much lower risk of ischemic stroke than their white counterparts. 22, 23 As the same time, the baseline risk of ICH, the greatest barrier to anticoagulation therapy, was reportedly higher among Chinese, [5] [6] [7] as well as in other Asian populations. Thereby, the use of long-term anticoagulation for stroke prevention in Chinese has been low. 8, 10 Recent registry data of Chinese populations from Hong Kong 8 and Beijing, 24 as well as subanalyses of data from the different NOAC trials focusing on Asian populations, [25] [26] [27] have demonstrated consistently that the risk of ischemic stroke in Chinese patients with AF was comparable with or even higher than that of whites. These findings are in accordance with the fact that globally, China is among the countries with the highest stroke rates. 28 Although Chinese patients with AF receiving warfarin therapy have a higher risk of ICH compared with white counterparts, net clinical benefit analyses favor warfarin therapy over aspirin and no therapy in almost all combinations of CHA 2 DS 2 -VASc and HAS-BLED scores. 8 Indeed, the net benefit of warfarin therapy is greatest among those at high risk of both stroke and ICH.
Another major stumbling block to stroke prevention in AF in Chinese population is the poor quality of anticoagulation control, as well as access to structured anticoagulation monitoring. In contemporary randomized trials, 11, 12 TTR varied greatly by country, but Asian populations (particularly Chinese) were among those with lowest TTRs. 11, 12 Outside trial settings, quality of anticoagulation would be expected to be even worse, as in the present cohort with the median TTR among Chinese patients with AF being as low as 38.8%. As the poor TTR could well be the result of poor standard of clinical practices, there are other plausible explanations. For instance, the optimal INR range of 2.0 to 3.0 is well established in white populations 29 ; however, given the higher baseline ICH risk among Asian particularly Chinese, [5] [6] [7] there is a widespread perception that Asian/Chinese might need a lower target INR (eg, INR, 1.6-2.6) to avoid this deadliest complication, albeit the lack of good clinical evidence. 30, 31 Nonetheless, the so-called optimal INR in Asian/Chinese would not be available unless there is a large randomized controlled trials in Chinese to compare the efficacy and safety of warfarin in different ranges of INR. In addition, it is well known that many traditional Chinese medicines have been shown to 
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